Artia Global Partners Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Artia Global Partners Lp disclosed 40 stock positions valued at approximately $526.03M as of quarter-end June 30, 2026. The largest holdings include ABIVAX SA, INSMED INC, and TREVI THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 40
- Portfolio Value
- $526.03M
Holdings by Sector
Artia Global Partners Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| ABIVAX SA | ABVX | Healthcare | 13.08% | 516,447 | -84,300 | -14.03% | $68,821,727 |
| INSMED INC | INSM | Healthcare | 11.94% | 589,052 | -39,660 | -6.31% | $62,804,724 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 7.84% | 2,210,852 | +197,250 | +9.80% | $41,232,390 |
| BRIGHTSPRING HEALTH SVCS INC | BTSG | Healthcare | 6.86% | 517,315 | +463,515 | +861.55% | $36,077,548 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 6.60% | 185,390 | +60,400 | +48.32% | $34,719,839 |
| ARGENX SE | ARGX | Healthcare | 5.25% | 29,739 | - | - | $27,590,952 |
| ALKERMES PLC | ALKS | Healthcare | 4.47% | 448,964 | +448,964 | +100.00% | $23,523,469 |
| TRAVERE THERAPEUTICS INC | TVTX | Healthcare | 3.66% | 339,033 | +268,333 | +379.54% | $19,260,465 |
| NEWAMSTERDAM PHARMA COMPANY | NAMSW | Other | 3.25% | 503,936 | - | - | $17,078,391 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 3.02% | 162,990 | - | - | $15,888,265 |
| QUEST DIAGNOSTICS INC | DGX | Healthcare | 2.62% | 65,122 | +24,305 | +59.55% | $13,802,608 |
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 2.18% | 144,376 | - | - | $11,447,573 |
| EYEPOINT INC | EYPT | Healthcare | 2.09% | 767,098 | - | - | $10,969,501 |
| ALUMIS INC | ALMS | Healthcare | 1.49% | 278,546 | -46,500 | -14.31% | $7,838,284 |
| VIKING THERAPEUTICS INC | VKTX | Healthcare | 1.34% | 180,731 | - | - | $7,050,316 |
| CELCUITY INC | CELC | Healthcare | 1.18% | 59,316 | +43,740 | +280.82% | $6,205,640 |
| CYTOKINETICS INC | CYTK | Healthcare | 1.14% | 70,700 | +54,400 | +333.74% | $6,022,933 |
| MERCK & CO INC | MRK | Healthcare | 1.14% | 46,700 | - | - | $6,000,950 |
| RAPPORT THERAPEUTICS INC | RAPP | Healthcare | 1.10% | 138,508 | - | - | $5,771,628 |
| JOHNSON & JOHNSON | JNJ | Healthcare | 1.09% | 22,600 | - | - | $5,739,722 |
| GUARDANT HEALTH INC | GH | Healthcare | 1.09% | 38,100 | +38,100 | +100.00% | $5,716,143 |
| ABSCI CORPORATION | ABSI | Healthcare | 1.02% | 464,444 | +464,444 | +100.00% | $5,382,906 |
| SCHOLAR ROCK HLDG CORP | SRRK | Healthcare | 1.01% | 96,285 | - | - | $5,295,675 |
| SIONNA THERAPEUTICS INC | SION | Other | 1.00% | 119,741 | - | - | $5,267,407 |
| ROIVANT SCIENCES LTD | ROIV | Healthcare | 0.87% | 129,800 | - | - | $4,593,622 |
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 0.76% | 98,800 | +33,300 | +50.84% | $4,014,244 |
| BIOGEN INC | BIIB | Healthcare | 0.76% | 18,437 | - | - | $3,983,498 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 0.75% | 65,000 | - | - | $3,923,400 |
| BELITE BIO INC | BLTE | Healthcare | 0.73% | 24,989 | - | - | $3,847,931 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 0.71% | 137,800 | - | - | $3,717,844 |
Showing 30 of 40 holdings in the latest reporting period.
Artia Global Partners Lp Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | XBI | SPDR Series Trust SPDR S&P Bio | PUT | 100,000 | $15,825,000 |
Showing 1 of 1 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.